Cargando…

Mechanisms of Cardiovascular System Injury Induced by COVID-19 in Elderly Patients With Cardiovascular History

The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents a great threat to healthcare and socioeconomics worldwide. In addition to respiratory manifestations, COVID-19 promotes cardiac injuries, particularly in elderly patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yaliu, Yan, Mengwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116509/ https://www.ncbi.nlm.nih.gov/pubmed/35600485 http://dx.doi.org/10.3389/fcvm.2022.859505

Ejemplares similares

Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
por: Diaz, Temistocles, et al.
Publicado: (2020)

Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system)
por: Ostovar, Afshin, et al.
Publicado: (2015)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy
por: Wang, Lun, et al.
Publicado: (2020)

Cardiovascular Impacts on COVID-19 Infected Patients
por: Raghavan, Somasundaram, et al.
Publicado: (2021)

Cardiovascular Complications of COVID-19 Vaccines
por: Liu, Runyu, et al.
Publicado: (2022)

Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
por: He, Nana, et al.
Publicado: (2021)

Cardiovascular Changes in Patients With COVID-19 From Wuhan, China
por: Song, Limin, et al.
Publicado: (2020)

Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19
por: Sritharan, Hari P., et al.
Publicado: (2023)

Telemedicine: Benefits for Cardiovascular Patients in the COVID-19 Era
por: Ghilencea, Liviu-Nicolae, et al.
Publicado: (2022)

Editorial: Post-COVID-19 cardiovascular sequelae
por: Condurache, Dorina-Gabriela, et al.
Publicado: (2023)

The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
por: Ellison-Hughes, Georgina M., et al.
Publicado: (2020)

Pyroptosis: Role and Mechanisms in Cardiovascular Disease
por: Chen, Xinzhe, et al.
Publicado: (2022)

Editorial: Cardiovascular neuromodulation: mechanisms and therapies
por: Hunt, Deborah, et al.
Publicado: (2023)

Radiation-Induced Cardiovascular Disease: Mechanisms and Importance of Linear Energy Transfer
por: Sylvester, Christopher B., et al.
Publicado: (2018)

Editorial: Multicellularity in the Cardiovascular System
por: Madeddu, Paolo, et al.
Publicado: (2019)

Cardiovascular Disease and COVID-19: Insight From Cases With Heart Failure
por: Yi, Yang, et al.
Publicado: (2021)

The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease
por: Zhang, Li-Li, et al.
Publicado: (2022)

Smoking in Patients With Chronic Cardiovascular Disease During COVID-19 Lockdown
por: Chagué, Frédéric, et al.
Publicado: (2022)

The Additive Value of Cardiovascular Magnetic Resonance in Convalescent COVID-19 Patients
por: Borlotti, Alessandra, et al.
Publicado: (2022)

Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease
por: Li, Yuman, et al.
Publicado: (2021)

COVID-19: The Cause of the Manifested Cardiovascular Complications During the Pandemic
por: Bandopadhyay, Audditiya, et al.
Publicado: (2021)

Repostioning of Telemedicine in Cardiovascular World Post-COVID-19 Pandemic
por: Sharma, Kamal, et al.
Publicado: (2022)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Mechanisms of Post-critical Illness Cardiovascular Disease
por: Owen, Andrew, et al.
Publicado: (2022)

Editorial: Immune and autoimmune mechanisms in cardiovascular disease
por: Winkels, Holger, et al.
Publicado: (2023)

Editorial: The Serpin Family in the Cardiovascular System
por: Bouton, Marie-Christine, et al.
Publicado: (2022)

Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross- sectional cohort: Cardiovascular Injury due to Tobacco Use study
por: Keith, Rachel J, et al.
Publicado: (2018)

Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19
por: Lozahic, Caroline, et al.
Publicado: (2021)

Temporal trends in cardiovascular care: Insights from the COVID-19 pandemic
por: Kodsi, Matthew, et al.
Publicado: (2022)

Gender discrepancies in predictors for newly onset cardiovascular events and metabolic syndrome in elderly patients from rural China
por: Yu, Shasha, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

Editorial: Mechanisms and Implications of the Aging of Cardiovascular Regenerative Cells
por: Beltrami, Antonio P., et al.
Publicado: (2018)

Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
por: Papazoglou, Panagiota, et al.
Publicado: (2021)

Editorial: Exosomes in cardiovascular diseases: Mechanism, diagnosis, and therapy
por: Zhang, Xiao, et al.
Publicado: (2022)

Editorial: Receptors in cardiovascular diseases: Mechanisms, diagnosis, and treatment
por: Shen, Shutong, et al.
Publicado: (2023)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Systems Medicine as an Emerging Tool for Cardiovascular Genetics
por: Haase, Tina, et al.
Publicado: (2016)

Heterocellularity and Cellular Cross-Talk in the Cardiovascular System
por: Perbellini, Filippo, et al.
Publicado: (2018)

Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
por: Glynn, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qrkm1ts1hl76vdi791mvm0k73d